Aaron Farberg, MD shares his perspective on buy and bill as a business strategy for dermatology practices and how it can improve patient care. "As dermatologists we constantly innovate and find new products to incorporate into our practice to improve the care we provide to our patients with skin diseases. Buy and bill can simply be an extension of the work you are already doing, and competent practice managers can incorporate these strategies based on your specific practice patterns and allow you to stay focused on your patients" https://hubs.li/Q02w_03-0
Verrica Pharmaceuticals
Pharmaceutical Manufacturing
West Chester, Pennsylvania 11,140 followers
We are developing novel treatments that provide meaningful benefits for people living with skin diseases.
About us
Verrica Pharmaceuticals Inc. is a dermatology therapeutics company developing medications for skin diseases requiring medical interventions. We believe there’s a better way to safely and effectively bring relief to patients, deliver peace of mind to parents and caregivers, and advance accessible therapies to prescribers and payers. We are focused on changing the narrative around skin diseases and making treatment a more efficient process for both physicians and patients. Headquartered in West Chester, Pennsylvania, Verrica was founded in 2013. We are led by a seasoned management team with extensive pharmaceutical industry experience ranging from drug development through commercialization and collectively launched more than 50 products.
- Website
-
http://www.Verrica.com
External link for Verrica Pharmaceuticals
- Industry
- Pharmaceutical Manufacturing
- Company size
- 51-200 employees
- Headquarters
- West Chester, Pennsylvania
- Type
- Public Company
- Founded
- 2013
- Specialties
- Dermatology and Pediatrics
Locations
-
Primary
44 West Gay Street
Suite 400
West Chester, Pennsylvania 19380, US
Employees at Verrica Pharmaceuticals
Updates
-
Happy National Dermatologist Day to all the skin experts helping their patients live better lives. At Verrica Pharmaceuticals, we deeply appreciate your dedication to skin health and innovation within dermatology. You play a vital role in addressing real patient needs, and your expertise is essential in developing new treatments and therapies.
-
Learn more about our Sales Team Expansion opportunities at www.verrica.com/careers
-
Putting the finishing touches in place for #FallClinical23. Join us Friday and Saturday in the Bandol room for a hands on demonstration with the YCANTH applicator. Join us today at 11:30 for a product theater hosted by Dr. Adelaide Hebert in the Meursault 2 room.
-
Verrica Pharmaceuticals reposted this
“Nothing’s easy, but it’s all about perseverance, commitment and steadfast leadership.” Celebrating five years #NasdaqListed, Verrica Pharmaceuticals President & CEO Ted White sits down with Nasdaq to reflect on the past five years of being a public company, and what $VRCA is looking to achieve in the years to come.
-
Verrica Pharmaceuticals reposted this
Join us on October 11th at 11am ET for a virtual KOL Event with Verrica Pharmaceuticals (#VRCA), featuring Mark D. Kaufmann MD, Michael Cameron, MD FAAD, and Mercedes Gonzalez, MD discussing the recent approval of YCANTH™ (VP-102) as the only product approved by the FDA to treat #molluscum in adult and pediatric patients two years of age and older. Register here: https://lnkd.in/eM7T5qHN
-
Verrica Pharmaceuticals reposted this
Verrica Pharmaceuticals is ringing in 5️⃣ years as a #NasdaqListed company. 🛎️ $VRCA is a dermatology therapeutics company developing novel treatments that provide meaningful benefits for people living with skin diseases. We look forward to supporting their growth and progress as they continue to innovate dermatological treatments.
-
IMPORTANT NEWS: The FDA has issued six warning letters to retail giants including Amazon and Walmart for selling unapproved products online for the treatment of molluscum contagiosum. “[The] FDA is concerned that people are forgoing or delaying proper diagnosis and treatment of a potentially serious, undiagnosed health condition by purchasing and using an unapproved drug product claiming to treat molluscum.” The FDA also issued warning letters to four companies making the unapproved molluscum products. https://lnkd.in/eGU8kmXA